MUSTANG BIO, INC. Liabilities Assumed
MUSTANG BIO, INC. (MBIO) reported Liabilities Assumed of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-29.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2018-03-29
- MUSTANG BIO, INC. liabilities assumed for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- MUSTANG BIO, INC. liabilities assumed for the quarter ending 2016-12-31 was $159.00K.
- MUSTANG BIO, INC. liabilities assumed for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- MUSTANG BIO, INC. liabilities assumed for fiscal 2016 was $793.00K.
| Period end | Liabilities Assumed 3 month | Liabilities Assumed 7 month | Liabilities Assumed 9 month | Liabilities Assumed 10 month | Liabilities Assumed 12 month |
|---|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $0.00 10-K · filed 2018-03-29 | |||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | ||||
| 2016-12-31 | $159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $793.00K 10-K · filed 2018-03-29 | |||
| 2016-09-30 | $634.00K 10-Q · filed 2017-11-14 | ||||
| 2015-12-31 | $0.00 10-K · filed 2018-03-29 | ||||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |